These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 38727697)

  • 1. Helicobacter pylori infection does not influence the progression from gastroesophageal reflux disease to Barrett's esophagus to esophageal adenocarcinoma.
    Edhi A; Gangwani MK; Aziz M; Jaber F; Khan Z; Inamdar S; Thrift AP; Desai TK
    Minerva Gastroenterol (Torino); 2024 May; ():. PubMed ID: 38727697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Helicobacter pylori Infection Is Associated With Reduced Risk of Barrett's Esophagus: An Analysis of the Barrett's and Esophageal Adenocarcinoma Consortium.
    Wang Z; Shaheen NJ; Whiteman DC; Anderson LA; Vaughan TL; Corley DA; El-Serag HB; Rubenstein JH; Thrift AP
    Am J Gastroenterol; 2018 Aug; 113(8):1148-1155. PubMed ID: 29880962
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Polyzos SA; Zeglinas C; Artemaki F; Doulberis M; Kazakos E; Katsinelos P; Kountouras J
    Ann Gastroenterol; 2018; 31(1):8-13. PubMed ID: 29333062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between Helicobacter pylori and Barrett's esophagus, erosive esophagitis, and gastroesophageal reflux symptoms.
    Rubenstein JH; Inadomi JM; Scheiman J; Schoenfeld P; Appelman H; Zhang M; Metko V; Kao JY
    Clin Gastroenterol Hepatol; 2014 Feb; 12(2):239-45. PubMed ID: 23988686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Barrett's esophagus with
    Ma S; Guo X; Wang C; Yin Y; Xu G; Chen H; Qi X
    Ther Adv Chronic Dis; 2022; 13():20406223221117971. PubMed ID: 36034104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Laryngopharyngeal reflux symptoms better predict the presence of esophageal adenocarcinoma than typical gastroesophageal reflux symptoms.
    Reavis KM; Morris CD; Gopal DV; Hunter JG; Jobe BA
    Ann Surg; 2004 Jun; 239(6):849-56; discussion 856-8. PubMed ID: 15166964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms for the Sex-Specific Effect of H. Pylori on Risk of Gastroesophageal Reflux Disease and Barrett's Esophagus.
    Wang SE; Dashti SG; Hodge AM; Dixon-Suen SC; Castaño-Rodríguez N; Thomas RJS; Giles GG; Milne RL; Boussioutas A; Kendall BJ; English DR
    Cancer Epidemiol Biomarkers Prev; 2022 Aug; 31(8):1630-1637. PubMed ID: 35654416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Helicobacter pylori and esophageal cancer risk: a meta-analysis.
    Islami F; Kamangar F
    Cancer Prev Res (Phila); 2008 Oct; 1(5):329-38. PubMed ID: 19138977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective evaluation of the prevalence of gastric Helicobacter pylori infection in patients with GERD, Barrett's esophagus, Barrett's dysplasia, and Barrett's adenocarcinoma.
    Weston AP; Badr AS; Topalovski M; Cherian R; Dixon A; Hassanein RS
    Am J Gastroenterol; 2000 Feb; 95(2):387-94. PubMed ID: 10685740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Helicobacter pylori infection and Barrett's esophagus: a systematic review and meta-analysis.
    Wang C; Yuan Y; Hunt RH
    Am J Gastroenterol; 2009 Feb; 104(2):492-500; quiz 491, 501. PubMed ID: 19174811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Helicobacter pylori infection reduces the risk of Barrett's esophagus: A meta-analysis and systematic review.
    Erőss B; Farkas N; Vincze Á; Tinusz B; Szapáry L; Garami A; Balaskó M; Sarlós P; Czopf L; Alizadeh H; Rakonczay Z; Habon T; Hegyi P
    Helicobacter; 2018 Aug; 23(4):e12504. PubMed ID: 29938864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leukocyte telomere length in relation to the risk of Barrett's esophagus and esophageal adenocarcinoma.
    Wennerström EC; Risques RA; Prunkard D; Giffen C; Corley DA; Murray LJ; Whiteman DC; Wu AH; Bernstein L; Ye W; Chow WH; Vaughan TL; Liao LM
    Cancer Med; 2016 Sep; 5(9):2657-65. PubMed ID: 27384379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Helicobacter pylori infection in Barrett's esophagus and the genesis of esophageal adenocarcinoma.
    Clark GW
    World J Surg; 2003 Sep; 27(9):994-8. PubMed ID: 14560364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of Helicobacter pylori on the presence of Barrett's esophagus in Azerbaijan, a high-prevalence area of infection.
    Aghayeva S; Mara KC; Katzka DA
    Dis Esophagus; 2019 Dec; 32(11):. PubMed ID: 31175364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Helicobacter pylori infection is associated with reduced risk of Barrett's esophagus: a meta-analysis and systematic review.
    Du YL; Duan RQ; Duan LP
    BMC Gastroenterol; 2021 Dec; 21(1):459. PubMed ID: 34876031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Central adiposity is associated with increased risk of esophageal inflammation, metaplasia, and adenocarcinoma: a systematic review and meta-analysis.
    Singh S; Sharma AN; Murad MH; Buttar NS; El-Serag HB; Katzka DA; Iyer PG
    Clin Gastroenterol Hepatol; 2013 Nov; 11(11):1399-1412.e7. PubMed ID: 23707461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of Helicobacter pylori infection in 190 control subjects and in 236 patients with gastroesophageal reflux, erosive esophagitis or Barrett's esophagus.
    Csendes A; Smok G; Cerda G; Burdiles P; Mazza D; Csendes P
    Dis Esophagus; 1997 Jan; 10(1):38-42. PubMed ID: 9079272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Helicobacter pylori eradication treatment and the risk of Barrett's esophagus and esophageal adenocarcinoma.
    Doorakkers E; Lagergren J; Santoni G; Engstrand L; Brusselaers N
    Helicobacter; 2020 Jun; 25(3):e12688. PubMed ID: 32175626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of Barrett's Esophagus and Esophageal Adenocarcinoma With and Without Gastroesophageal Reflux: A Systematic Review and Meta-analysis.
    Saha B; Vantanasiri K; Mohan BP; Goyal R; Garg N; Gerberi D; Kisiel JB; Singh S; Iyer PG
    Clin Gastroenterol Hepatol; 2024 Jul; 22(7):1381-1394.e7. PubMed ID: 37879525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic Obstructive Pulmonary Disease and the Risk of Esophagitis, Barrett's Esophagus, and Esophageal Adenocarcinoma: A Primary Care Case-Control Study.
    Menon S; Nightingale P; Trudgill N
    J Clin Gastroenterol; 2019; 53(10):e451-e455. PubMed ID: 31008868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.